Pioneering Gene Injection Restores Sight in Patients With Most Common Form of Inherited Blindness
8th October 2018
Scientists have hailed the results of the world’s first gene therapy trial for blindness after 14 patients with one of the most common inherited forms of the disease experienced “significant” gains or arrested deterioration of their vision.
Oxford University researchers, working with the NHS, injected a virus containing a missing gene into the rear of the eyes of patients suffering from choroideremia.
Of the 12 who received the treatment without suffering any complications, all have demonstrated improved or maintained vision since having the injection, some as long as five years ago.